Extract from Business Questions (Commons): DIPG - May 2

Diffuse intrinsic pontine glioma—DIPG—is the second most common type of primary high-grade brain tumour in children, affecting around 40 children each year in the United Kingdom. It is not amenable to surgery, and radiotherapy is only for palliative purposes. Only 10% of children affected survive longer than two years after diagnosis, and that prognosis has not improved in the past 40 years. Will the Leader of the House make a statement on the need to increase funding for research into DIPG, to further improve and enhance recognition and treatment of this devastating illness as we approach DIPG Awareness Day on 17 May?

I am grateful to the hon. Lady for raising this issue. Quite often in the House, colleagues raise rare and unusual forms of cancers and other  illnesses, and it is absolutely right that they do that. While we can all be proud of the significant increase in people surviving cancers in general, it is concerning, as she says, that those survival rates have not improved in many decades. Health Question Time is on Tuesday 7 May, and I encourage her to raise her issue directly with Ministers then.